Table 1.
Clinicopathological characteristics of the patients
| Characteristic | MELF-positive group (n = 49) | MELF-negative group (n = 51) | p-value |
|---|---|---|---|
| Age (yr) | 64.2 ± 4.8 | 63.8 ± 5.2 | .982a |
| FIGO stage | .942b | ||
| I | 12 | 11 | |
| II | 23 | 25 | |
| III | 14 | 15 | |
| Tumor grade | .855b | ||
| G1 | 20 | 22 | |
| G2 | 23 | 22 | |
| G3 | 6 | 7 | |
| Lymphovascular invasion | .115c | ||
| Present | 29 | 22 | |
| Absent | 20 | 29 | |
| Myometrial invasion (%) | > .99c | ||
| < 50 | 10 | 9 | |
| > 50 | 39 | 42 |
MELF, microcystic, elongated and fragmented; FIGO, International Federation of Gynecology and Obstetrics.
a
Mann-Whitney U test;
b
Kruskal-Wallis test;
c
Fisher’s two-tailed exact test.